DK452274A - - Google Patents

Info

Publication number
DK452274A
DK452274A DK452274A DK452274A DK452274A DK 452274 A DK452274 A DK 452274A DK 452274 A DK452274 A DK 452274A DK 452274 A DK452274 A DK 452274A DK 452274 A DK452274 A DK 452274A
Authority
DK
Denmark
Application number
DK452274A
Other languages
Danish (da)
Inventor
H Wissmann
R Geiger
W Konig
H Kruse
K Seeger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK452274A publication Critical patent/DK452274A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK452274A 1973-08-25 1974-08-23 DK452274A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2343035A DE2343035C2 (de) 1973-08-25 1973-08-25 Pyroglutamyl-histidyl-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2416428A DE2416428C2 (de) 1973-08-25 1974-04-04 Pyroglutamyl-histidyl-prolinamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
DK452274A true DK452274A (de) 1975-04-28

Family

ID=25765691

Family Applications (1)

Application Number Title Priority Date Filing Date
DK452274A DK452274A (de) 1973-08-25 1974-08-23

Country Status (12)

Country Link
US (1) US3931139A (de)
JP (1) JPS5756467B2 (de)
BE (1) BE819198A (de)
CA (1) CA1029369A (de)
CH (2) CH603558A5 (de)
DE (2) DE2343035C2 (de)
DK (1) DK452274A (de)
FR (1) FR2241312B1 (de)
GB (1) GB1463190A (de)
IE (1) IE39766B1 (de)
LU (1) LU70783A1 (de)
NL (1) NL7411111A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523598A (en) * 1975-03-08 1978-09-06 Reckitt & Colmann Prod Ltd Tripeptides
US4125605A (en) * 1977-10-19 1978-11-14 The United States Government Method of employing oral TRH
US4215110A (en) * 1978-09-22 1980-07-29 Merck & Co., Inc. Method of treating hypertension
US4426378A (en) 1981-04-09 1984-01-17 The United States Of America As Represented By The Secretary Of The Army Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant
FR2564096B1 (fr) * 1984-05-11 1988-02-19 Anvar Derives lipophiles de muramylpeptides ayant des proprietes d'activation des macrophages, compositions les contenant et procede pour les obtenir
US4818531A (en) * 1985-02-06 1989-04-04 Eli Lilly And Company Growth hormone and thyroid hormone
GB2227658A (en) * 1989-02-03 1990-08-08 Cellana Thyrotropin releasing hormone (trh) composition for enhancing immune function
CA2565843A1 (en) * 2004-05-06 2005-11-17 Pfizer Inc. Novel compounds of proline and morpholine derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725380A (en) * 1969-04-05 1973-04-03 Hoechst Ag Method of synthesizing peptides in the presence of a carbodiimide and a 1-hydroxy-benzotriazole
BE754343A (fr) * 1969-08-01 1971-02-03 Hoechst Ag Procede de preparation de peptides

Also Published As

Publication number Publication date
GB1463190A (en) 1977-02-02
IE39766L (en) 1975-02-25
DE2343035C2 (de) 1982-04-01
CA1029369A (en) 1978-04-11
JPS5756467B2 (de) 1982-11-30
IE39766B1 (en) 1978-12-20
NL7411111A (nl) 1975-02-27
CH603558A5 (de) 1978-08-31
FR2241312A1 (de) 1975-03-21
LU70783A1 (de) 1976-08-19
FR2241312B1 (de) 1978-07-21
CH603560A5 (de) 1978-08-31
DE2343035A1 (de) 1975-03-06
BE819198A (fr) 1975-02-26
DE2416428C2 (de) 1984-07-26
JPS5070368A (de) 1975-06-11
US3931139A (en) 1976-01-06
DE2416428A1 (de) 1975-10-23
AU7259174A (en) 1976-02-26

Similar Documents

Publication Publication Date Title
AR201758A1 (de)
AU476761B2 (de)
AU465372B2 (de)
AR201235Q (de)
AR201231Q (de)
AU474593B2 (de)
AU474511B2 (de)
AU474838B2 (de)
AU465453B2 (de)
AU465434B2 (de)
AU471343B2 (de)
JPS5138392B2 (de)
AU450229B2 (de)
FR2241312B1 (de)
AR201229Q (de)
AU466283B2 (de)
AU476696B2 (de)
AU472848B2 (de)
AR199451A1 (de)
AU477823B2 (de)
AU476873B1 (de)
AR200885A1 (de)
AR200256A1 (de)
AU471461B2 (de)
AU461342B2 (de)

Legal Events

Date Code Title Description
ATS Application withdrawn